Transmyocardial laser revascularization.

Journal of Cardiac Surgery
Keith A Horvath

Abstract

It has been almost a decade since transmyocardial laser revascularization (TMR) was approved for clinical use in the United States. The safety of TMR was demonstrated initially with nonrandomized studies in which TMR was used as the only treatment for patients with severe angina. TMR efficacy was proven after multiple randomized controlled trials. These revealed significant angina relief compared to maximum medical therapy in patients with diffuse coronary disease not amenable to conventional revascularization. In light of these results, TMR has been used as an adjunct to coronary artery bypass grafting (CABG). By definition, patients treated with this combined therapy have more severe coronary disease and comorbidities that are associated with end-stage atherosclerosis. Combination CABG + TMR has resulted in symptomatic improvement without additional risk. The likely mechanism whereby TMR has provided benefit is the angiogenesis engendered by the laser-tissue interaction. Improved perfusion and concomitant improvement in myocardial function have been observed post-TMR. Additional therapies to enhance the angiogenic response include combining TMR with stem cell-based treatments, which appear to be promising future endeavors.

References

Nov 1, 1995·Circulation·O H FrazierW H Moore
Jan 1, 1995·Journal of the American College of Cardiology·K A HorvathL H Cohn
Apr 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·D A CooleyW H Moore
Mar 1, 1996·The Annals of Thoracic Surgery·T KohmotoD Burkhoff
May 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·K A HorvathL H Cohn
May 1, 1996·The Annals of Thoracic Surgery·D BurkhoffC R Smith
Oct 1, 1996·The Annals of Thoracic Surgery·K J FleischerW A Baumgartner
Sep 1, 1996·Journal of Cardiac Surgery·T KrabatschR Hetzer
Aug 1, 1997·The Annals of Thoracic Surgery·P E FisherD Burkhoff
Aug 1, 1997·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·N TrehanA Karlekar
Jan 22, 1998·The Journal of Thoracic and Cardiovascular Surgery·K F KwongT M Sundt
Apr 4, 1998·The Annals of Thoracic Surgery·A MilanoU Bortolotti
May 16, 1998·The Annals of Thoracic Surgery·O H FrazierD A Cooley
May 15, 1998·Journal of the American College of Cardiology·N YamamotoD Burkhoff
May 22, 1998·The Annals of Thoracic Surgery·K A Horvath
Jun 17, 1998·The Journal of Thoracic and Cardiovascular Surgery·J E SigelN B Ratliff
Jun 26, 1998·Journal of Clinical Laser Medicine & Surgery·T SpanierD Burkhoff
Aug 6, 1998·The Annals of Thoracic Surgery·M P PelletierR C Chiu
Oct 13, 1998·The Annals of Thoracic Surgery·K A HorvathD A Fullerton
Nov 11, 1998·Ultrasound in Medicine & Biology·N B Smith, K Hynynen
Feb 4, 1999·The Annals of Thoracic Surgery·G C HughesK P Landolfo
Feb 4, 1999·Seminars in Thoracic and Cardiovascular Surgery·K A Kadipasaoglu, O H Frazier
Apr 10, 1999·The Annals of Thoracic Surgery·K A KadipaşaogluO H Frazier
Jul 14, 1999·Circulation·T Al-SheikhE D Engelstein
Sep 4, 1999·The Annals of Thoracic Surgery·G M HirschJ A Armour
Sep 30, 1999·The New England Journal of Medicine·K B AllenW W O'Neill
Oct 3, 1999·The Journal of Thoracic and Cardiovascular Surgery·M M GrahamR F Davies
Oct 27, 1999·The Journal of Thoracic and Cardiovascular Surgery·V ChuR C Chiu
Oct 30, 1999·The Annals of Thoracic Surgery·B G HattlerS W Boyce
Jun 7, 2000·Journal of the American College of Cardiology·F ShawlS T Shahab

❮ Previous
Next ❯

Citations

Jan 15, 2011·Bulletin of Experimental Biology and Medicine·D S SergeevichevL M Nepomnyashchikh
Mar 1, 1997·The Annals of Thoracic Surgery·E D JansenA J Welch
Aug 6, 1998·The Annals of Thoracic Surgery·M P PelletierR C Chiu
Jan 1, 2011·Laser Therapy·Masayoshi OkadaHiroyuki Horii
Aug 24, 2012·Theranostics·Lorenzo DevezaFan Yang
Aug 9, 2011·Current Problems in Cardiology·Kevin L Greason, Hartzell V Schaff
Jan 9, 2010·The Journal of Surgical Research·Aaron M Abarbanell
Jan 20, 2011·Lasers in Surgery and Medicine·Soren K EstvoldKeith A Horvath
Jan 4, 2015·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Gianluca AlunniAmir Lerman
May 27, 2017·Interactive Cardiovascular and Thoracic Surgery·Mohammad A BashirKalpaj Parekh
Dec 1, 2017·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Ryan J AveryZain I Khalpey
Nov 1, 2008·Microbial Biotechnology·Roland J Siezen, Herwig Bachmann
Feb 28, 2015·The Cochrane Database of Systematic Reviews·Eduardo BrionesJosé-Ramón Rueda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.